ABSTRACT. In the present study, a novel antigenic protein expressed in the piroplasm stage of Theileria orientalis was characterized. A 4,707 bp genomic fragment amplified by PCR contained two open reading frames (ORFs). The deduced amino acid sequence of the first ORF showed significantly high similarlity to the ubiquitin carboxy terminal hydrolases/proteases while the second ORF (To ORF2) showed homology to several surface antigens of plasmodia. To ORF2 was expressed to determine whether the protein product is expressed by the parasite. In western blot analysis, bovine antiserum from a T. orientalis-infected calf recognized the recombinant protein containing a C-terminal part of the ORF expressed by baculovirus system. Western blot analysis with the anti-To ORF2 mouse serum recognized a 48 kDa protein in T. orientalis piroplasm lysates. Indirect immunofluorescence antibody test by confocal scanning laser microscopic analysis showed that antisera against the recombinant protein recognized T. orientalis piroplasm in the infected erythrocyte. The results from this study indicate that To ORF2 protein is expressed at the piroplasm stage and is immunogenic. This novel antigenic To ORF2 protein could be exploited for vaccine development against bovine piroplasmosis. KEY WORDS: Apicomplexa, parasite vaccine, piroplasm, Theileria orientalis.
Theileria parasites are tick-transmitted, intracellular protozoa belonging to the phylum Apicomplexa, which cause disease in wild and domestic ruminants. Two Theileria species, namely T. parva and T. annulata, are highly pathogenic, causing lymphoproliferative diseases in cattle. They cause significant economic losses to animal husbandry in tropical and subtropical countries [18, 22, 28, 35] . On the other hand, T. orientalis cause bovine piroplasmosis, a disease characterized by anemia in infected cattle [17] . The disease occasionally cause death especially in severe cases [34] and lead to great economic loss in cattle production mainly in Japan and Korea [1, 17] .
Recent attempts to develop subunit vaccines against Theileria parasites have focused on the sporozoite surface antigens (p67 of T. parva and SPAG-1 of T. annulata). These antigens were reported to give partial protection when different delivery systems and adjutants were tried [21, 26] . However, little is known on stage specific expression of T. orientalis proteins. Only two piroplasm proteins, the major piroplasm surface protein (MPSP) [12, 15] and P23 [29] have been reported although the erythrocytic stage is responsible for the pathology associated with theileriosis caused by T. orientalis. For other stages such as sporozoite or schizont, no specific genes have been identified so far. It was reported that vaccination with synthetic MPSP peptides reduced parasitemia [24] , but effective and safe vaccine have not yet been developed for T. orientalis.
In efforts to develop vaccines against T. orientalis, we have searched for genes specifically expressed in the sporozoite, schizont or piroplasm stages. In the process of searching for these genes, the deduced protein products showing similarity to several surface antigens of malaria parasites, and those that may be important as vaccine candidates, were identified. The possible product of a gene (To ORF2) that was isolated by PCR was further characterized. In this study, we report the characterization of a gene encoding a novel antigenic protein of T. orientalis and its immunoreactivity.
MATERIALS AND METHODS

T. orientalis piroplasm preparation:
The purification of T. orientalis piroplasm derived from the Ikeda stock [8] was performed according to the previously described method [33] with some modifications. Briefly, blood was collected when the parasitemia in a calf experimentally infected with T. orientalis (Shintoku stock) reached 30%. This stock originally consisted of two parasite types (Ikeda-and Chitosegenotypes), but only the Ikeda-type parasite was isolated at the time of sample collection as revealed by allele-specific PCR [13] . The blood was passed through a leukocyte filter (Terumo, Japan) for the removal of bovine leukocytes. The purified bovine erythrocytes were washed three times with cold phosphate-buffered saline (PBS) and the final sediment was resuspended with an equal volume of PBS. Erythrocytes were disrupted by nitrogen gas cavitation and piroplasms were purified by differential centrifugation as described previously [30] . The purified piroplasms were stored at -80°C until further use.
Extraction of the T. orientalis genomic DNA: The puri-fied piroplasms of T. orientalis were suspended in a DNA extraction buffer (10 mM Tris-HCl (pH8.0), 150 mM NaCl, and 10 mM EDTA) and digested with 0.1% SDS and 100 mg/ml proteinase K at 55°C for 2 hr. The genomic DNA was then extracted with an equal volume of phenol-chloroform, precipitated with ethanol, and suspended in TE buffer (10 mM Tris-HCl, 1 mM EDTA pH 8.0). PCR cloning and DNA sequencing: While attempting to clone the p67 gene homologue of T. orientalis by PCR, a set of primers were designed based on genomic DNA sequence information around the T. parva P67 gene [19] . The forward (5'-TTGAACCCCTCACCAGACGCTAAG-3') and reverse (5'-CGAAAAAGTGAAGGTTGTGCTCG-3') primers were designed on the basis of T. orientalis nucleotide sequences of a DnaJ homologue [Sako et al., unpublished] and a GTP-binding protein homologous gene obtained from expressed sequence tag analysis [Kim et al., unpublished] . Both genes are expected to be adjacent to a loci containing a cysteine proteinase and the p67 gene.
PCR was performed in 50 µl of a mixture (20 mM TrisHCl (pH 8.0), 100 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 0.5% Tween 20, 0.5% Nonidet P-40, and 50% glycerol) containing 10 mM of each primer, 0.5 µg of the template genomic DNA, 2.5 mM of dNTPs mixture, and 5 units of Taq DNA polymerase (Takara, Japan). The mixture was subjected to 30 PCR amplification cycles at 96°C for 15 sec and 68°C for 3 min with a final extension at 72°C for 10 min. The desired bands were visualized by ethidium bromide staining.
A PCR product of about 4.7 kbp was amplified and cloned into pGEM-T easy vector (Promega, U.S.A.). The resultant plasmid (designated as pGEM/f 4.7) was subjected to complete nucleotide sequence analysis with a Big Dye Chain Termination kit (Applied Biosystem, U.S.A.) using an ABI 3100 automated sequencer (Applied Biosystem, U.S.A.). The open reading frames (ORFs) of the genomic sequence were determined by the MacVector program (Oxford Molecular Ltd., UK) and applied to a basic local alignment search tool (BLAST) on the National Center for Biotechnology Information (NCBI) database (http:// www4.ncbi.nlm.nih.gov/) to search for homologous proteins to the deduced amino acid sequences of the ORFs. The search for functional motifs of the predicted polypeptides was performed at the Sequence Motif Search website (http:/ /motif.genome.ad.jp).
Construction of a recombinant baculovirus: PCR was performed using forward (5'-ttgaatccATGAAAAACG-GAAAGGTGACGAAGGCGAGCTACC-3') and reverse (5'-acaagcttTCATTCTCGAGTGCACGAAGCTCGGGG-TAGTCGTA-3') primers for the N-terminal part of To ORF2 gene (To ORF2c), and using forward (5'-acggatccCGAGAATGAGTAACGTCAAGGTGGTC-3') and reverse (5'-acaagcttCAGTCGAGGTGGTCGTCGTTC-GACT-3') primers for the C-terminal part of To ORF2 gene (To ORF2c). A 1,239 bp long DNA fragment of To ORF2n and a 1,550 bp long DNA fragment of To ORF2c gene were amplified. EcoRI and HindIII digested To ORF2n product and BamHI and HindIII digested To ORF2c were inserted into the EcoRI and HindIII or BamHI and HindIII sites of pFast-Bac-Dual vector (Life Technologies, U.S.A.) in order to obtain the recombinant donor plasmids, pFBD/To ORF2n and pFBD/To ORF2c, respectively. The pFBD/To ORF2n and pFBD/To_ORF2c plasmids were introduced into Escherichia coli DH10Bac competent cells (Life Technologies, U.S.A.) and the resultant transposed-bacmid containing the To ORF2c gene was selected and transfected into Sf9 insect cells as described previously [36] . Two recombinant baculovirus, designated as AcTo ORF2c and AcTo ORF2n, were collected from the transfectant. Another recombinant virus, AcFB-D without any inserted genes [37] was used as a control. To express the recombinant proteins, Sf9 insect cells were seeded on a 6 well-culture plate (NUNK, Denmark) and infected with the recombinant baculovirus, AcTo ORF2 or AcFB-D, at a multiplicity of infection of 5 plaque-forming units per cell. At 72 hr postinfection, the infected cells were harvested according to a standard protocol and washed three times with cold PBS and stored at -20°C.
Preparation of the anti-To ORF2 gene product polyclonal antibody: To produce a C-terminal part of the To ORF2 gene product in E. coli, two types of primers (5'-acggatccGAGAATGAGTAACGTCAAGGTGGTC-3') and (5'-acaagcttCAGTCGAGGTGGTCGTCGTTCGACT-3') were designed on the basis of the nucleotide sequence of To ORF2c gene. In PCR using the p GEM/f4.7 as a DNA template, a 1,549 bp long DNA fragment containing the truncated To ORF2 gene was amplified, digested with BamHI and HindIII, purified from agarose gel, and then inserted into the BamHI and HindIII sites of pGEMEX2 (Promega, U.S.A.). The resultant plasmid, pGEMEX/To ORF2, was used to produce the insoluble To ORF2 gene product fused with a bacteriophage T7 gene 10 leader peptide in a competent E. coli BL21 (DE3). The transformed E. coli was washed three times with cold PBS, disrupted by sonication, and then centrifuged 1,800 × g for 10 min at 4°C. The pellet was resuspended with cold PBS to a final concentration of 10 mg/ml and used for immunizing mice. Eight-week-old female BALB/c mice were injected intraperitoneally (i.p.) with 2 mg of the recombinant To ORF2 antigen pre-mixed with an equal volume of complete Freund's adjuvant (Difco, U.S.A.). On days 14 and 28 post-immunization, the mice were boosted by i.p. injection of the same amount of recombinant antigen mixed with an equal volume of incomplete Freund's adjuvant (Difco, U.S.A.). Sera from the immunized mice was collected 10 days after the last booster immunization.
Indirect immunofluorescence antibody test (IFAT): Smears of T. orientalis infected bovine erythrocytes were fixed with 50% acetone-50% methanol solution for 3 min at -20°C and then air-dried. Fixed smears were incubated with the anti-To ORF2 gene product mouse serum for 30 min at 37°C. After washing three times with PBS, the smears were incubated with fluorescein isothiocyanate-conjugated antimouse goat immunoglobin G (IgG) (ICN Pharmaceuticals, U.S.A.) for 30 min at 37°C. The slides were washed three times with PBS, incubated with 25 µg/ml propidium iodide (PI) (Molecular probes, U.S.A.) and 50 µg/ml RNase A for 15 min at 37°C, and then mounted with 50% glycerol-PBS solution and visualized in a confocal laser scanning microscope (Leica, Germany).
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analyses:
For protein analysis, purified T. orientalis piroplasms antigen or infected insect cells expressing the AcTo ORF2 or AcFB-D were solubilized by heating at 100°C for 3 min with an equal volume of 2 × SDS sample buffer. Samples were loaded on a 10 or 15% polyacrylamide gel and the fractionated proteins were subsequently transferred onto PVDF membrane (Immobilon ® , Millipore, U.S.A.). After immersing in blocking buffer (5% skim milk and 0.05% tween-20 containing PBS) at 4°C over night, the membrane was incubated at room temperature for 1 hr either with anti-To ORF2 gene product mouse serum or bovine antiserum against T. orientalis. After washing, the membranes were incubated with alkaline phosphatase-conjugated anti-mouse IgG (Boehringer Mannheim, Germany) or horseradish peroxidase-conjugated anti bovine IgG (ICN Biomedicals, Inc., U.S.A.) at 37°C for 60 min. Positive signals were visualized with a BCIP/NBT-purple liquid substrate (Sigma, U.S.A.) or a substrate solution containing 0.5 mg/ml diaminobenzidine and 0.005% H 2 O 2 .
RESULTS AND DISCUSSION
We had started our experiment with the aim of searching for a T. parva P67 gene orthologue in the T. orientalis genome using PCR. A 4.7 kbp DNA fragment was amplified and its complete nucleotide sequence was determined (Fig. 1) . However, sequence analysis revealed that this fragment did not contain the p67 orthologue or its adjacent region when a search was conducted at the T. parva database (http://www.tigr.org). As shown in Fig. 1 , the fragment contained two ORFs (To ORF1 and To ORF2), which were also conserved in the T. parva genome (contig number 459, TIGR's T. parva genome database). The deduced amino acid sequence of the first ORF, designated as To ORF1 gene, showed significantly high similarity to the ubiquitin-carboxyl-terminal hydrolases (UCH) of mouse (35% identity over 368 amino acid overlap) (GeneBank accession numbers; AP002543) and yeast (33% identity over 367 amino acid overlap) (GeneBank accession numbers; P50101). Additionally, it contained two conserved domains, UCH-1 and UCH-2 in the UCH family [6, 11] (Data not shown).
The deduced amino acid sequence of the second ORF, To ORF2 gene, showed a certain degree of similarity to the surface antigens of Plasmodium parasites, such as merozoite surface antigen 2 (MSA2) (38% identity over 60 amino acid overlap) of P. falciparum (GeneBank accession number PFU07009) [7] and the circumsporozoite protein (CSP) (31% over 92 amino acid overlap) of P. vivax (GeneBank accession number U08981) [14] (Fig. 1B and C) . The MSA2 protein binds to the surface of erythrocytes and is required for merozoite attachment [23] , while the CSP is a vital surface antigen required for the development of sporozoites [16, 27, 31] and is a key target recognized by the host immune system and has emerged as one of the prime candidates for anti-malarial vaccine [19, 32] . No signal peptide or transmembrane sequences were identified in To ORF2, indicating that To ORF2 product may not be a surface protein.
For further characterization of possible product of this ORF, we attempted to express it.
Two truncated versions of To ORF2 gene (To ORF2n and To ORF2c) were expressed by using baculovirus expression system. As shown in Fig. 2A , 45 kDa and 55 kDa of recombinant proteins from AcTo ORF2n and AcTo ORF2c were expressed in infected Sf9 insect cells, respectively. Cell lysates containing AcTo ORF2c were recognized by bovine serum against T. orientalis in Western blot analysis (Fig.  2B) . To make sure of this, other four more bovine serums were also examined and showed positive reactions with AcTo ORF2c (data not shown), suggesting that To ORF2c gene product was expressed by the parasites and was immunogenic in infected animals. No immunoreaction was observed with To ORF2n gene product (lane 3), indicating that the N-terminal part of the protein does not induce antibodies in infected animals. The control AcFB-D cell lysate showed no immunoreaction as well (lane 2). No reactions were observed with negative bovine serum either (data not shown).
To ORF2c gene was expressed by the E. coli expression system (rTo ORF2) and used to produce antiserum. The specificity of the antiserum against rTo ORF2 was confirmed by the reaction with the baculovirus-expressed recombinant protein (AcTo ORF2c) and by the indirect immunofluorescent antibody test (IFAT) (Fig 3A, panel a) . In western blot analysis, mouse antiserum against the rTo ORF2c gene product reacted with a 55 kDa protein (Fig. 3B,  lane 2) . However, a molecular mass of 48 kDa of the native protein in the T. orientalis piroplasm lysate (Fig. 3B, lane 3) was identified. The expected molecular mass of To ORF2 product is about 99 kDa. This discrepancy in molecular mass may be due to cleavage by host or parasite proteinase. No reaction was observed with the control AcFB-D-infected cell lysate (Fig. 3B, lane 1) .
Confocal laser scanning microscopy analysis of IFAT with the anti-rTo ORF2 mouse serum revealed that anti-rTo ORF2 reacted with intraerythrocytic piroplasms as well as with free piroplasms released from erythrocytes (Fig. 4A) . No signals were observed with negative bovine serum (Fig.  4B) .
To ORF2 gene product contain several motifs found in proteins associated with erythrocyte membrane skeleton such as 1) band 4.1 family [EMTVDIRTPCKHVL-RYVSWALGVDPSHVLVF], a major structural element of the erythrocyte membrane skeleton that stabilizes the spectrin/actin cytoskeleton [10] , 2) adducin-related protein 1 [RVALARARRRARALVHRGR], a membrane-cytoskeleton-associated protein that promotes the assembly of the s p e c tr i n -a c t in n e t w o r k [ 3 8 ] , 3 ) p l e c t i n r e p e a t [ELAEPVQLPEEDEPLALAARHRGGRRVALARAR-RRARALVHRGRPELADQRAPAV] that may have a role in interacting with intermediate filament proteins and crosslinks these proteins with microtubules and microfilaments [9] . The presence of these motifs suggests there may be interaction between To ORF2 gene product and the erythrocyte membrane while it is expressed in the piroplasm stage. 
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Further studies are required to determine localization and function of this product, which plays a major role in the pathogenesis in T. orientalis. The fact that protection against parasitemia and clinical symptoms was achieved by immunization with soluble extracts of piroplasms, recombinant MPSP or its synthetic peptide [2] [3] [4] [5] 25] indicate that a strong humoral anti-piroplasm response is all that is required for protection, other piroplasm antigenic proteins including To ORF2 gene product are worth pursuing as a vaccine candidate.
